Heart Month: Artificial Heart Facts

Feb 9, 2015 3:55 PM ET
Campaign: Artificial Heart
The data presented are from professional references and represent the best information available to SynCardia Systems, Inc. as of December 31, 2014. For updates on the information, contact Don Isaacs, vice president of communications. *Caution- In the United States, the 50cc SynCardia temporary Total Artificial Heart, is an investigational device, limited by United States law to investigational use.

*/

The SynCardia temporary Total Artificial Heart and its predecessors make up 96% of all artificial hearts implanted in humans, making it the most widely used heart in the world. Learn more Heart Month facts at These 7 Artificial Heart Facts Could Help Save Your Life. 

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.

The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old. The longest a patient has lived with a SynCardia Heart was nearly four years (1,374 days) before receiving a successful donor heart transplant Sept. 11, 2011.

SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by more than 200 patients, accounting for over 120 years of support.